Идёт набор NCT06879730

Retrospective Evaluation of Minimally-Invasive Surgical Strategies in Ovarian Neoplasms (REMISSION Study)

— Наблюдательное Early-stage Epithelial Ovarian Cancer

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают: Это наблюдательное исследование: исследуемое лечение участникам по протоколу не назначают.
Кому может быть актуально: Состояния в реестре: Early-stage Epithelial Ovarian Cancer. Базовые параметры: Без ограничений · Женщины.
Что важно проверить: Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится: Италия
Следующий шаг: Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Не всё понятно в терминах? Прочитайте наш гид для пациентов →

Обзор

This observational study aims to evaluate the outcomes of patients with early-stage epithelial ovarian cancer who are treated with minimally invasive surgery (such as laparoscopic or robotic surgery). Specifically, the study will look at: 1. Post-Surgery Complications * What is the rate of complications within 30 days after surgery? * How often do patients require readmission to the hospital, re-operation, or conversion to open surgery? 2. Cancer Outcomes * What is the rate of cancer upstaging (when the cancer spreads to a more advanced stage during surgery for example because of an intra-operative ovarian cyst rupture)? * What are the overall survival and disease-free survival rates for patients treated with minimally invasive surgery? Researchers will compare two groups of patients: Group 1: Patients with early-stage ovarian cancer treated with minimally invasive surgery. Group 2: Patients with early-stage ovarian cancer treated with open surgery. The goal is to see if there are any differences in post-surgery complications, recovery, and cancer outcomes between the two groups. Fertility-Sparing Treatment: The study will also compare patients who are undergoing fertility-sparing treatments for early-stage ovarian cancer. Two subgroups will be looked at: * Patients receiving fertility-sparing surgery through a minimally invasive procedure. * Patients receiving fertility-sparing surgery through an open surgery. The same outcomes (complications, survival, etc.) will be assessed and compared between these two groups as well.

Первичные конечные точки

To assess the number of patients with 30-day post-operative complication in the two groups (minimally invasive surgery and open surgery) [Срок оценки: From surgery to post-operative day 30]
To assess the number of patients with 30-day post-operative hospital readmission in the two groups (minimally invasive surgery and open surgery) [Срок оценки: From surgery to post-operative day 30]
To assess the number of patients with 30-day post-operative reoperation in the two groups (minimally invasive surgery and open surgery) [Срок оценки: From surgery to post-operative day 30]
To assess the rate of upstaging in the two groups (minimally invasive surgery and open surgery) [Срок оценки: At the time of surgery]
To assess the rate of conversion in the minimally invasive surgery group [Срок оценки: At the time of surgery]

Вторичные конечные точки (1)

To analyze predictor of recurrence and oncological outcomes in terms of disease-free survival (DFS) and overall survival (OS) in the minimally invasive surgery and in the open surgery groups [Срок оценки: From the date of surgery to the date of the last follow-up or the date of recurrence/death, whichever occurs first, assessed up to 300 weeks]

Критерии участия

Критерии включения

Patients with apparent early-stage epithelial ovarian cancer at preoperative evaluation
Patients who underwent surgery between January 2014 and December 2023
Patients who underwent open or minimally invasive surgical staging (Laparoscopic or Robotic-assisted approach) or restaging procedure
Patients with final pathology report of Epithelial Ovarian Cancer